Literature DB >> 19208971

Molecular biology and pathogenesis of hepatitis E virus.

Vivek Chandra1, Shikha Taneja, Manjula Kalia, Shahid Jameel.   

Abstract

The hepatitis E virus (HEV) is a small RNA virus and the etiological agent for hepatitis E, a form of acute viral hepatitis. The virus has a feco-oral transmission cycle and is transmitted through environmental contamination, mainly through drinking water. Recent studies on the isolation of HEV-like viruses from animal species also suggest zoonotic transfer of the virus. The absence of small animal models of infection and efficient cell culture systems has precluded virological studies on the replication cycle and pathogenesis of HEV. A vaccine against HEV has undergone successful clinical testing and diagnostic tests are available. This review describes HEV epidemiology, clinical presentation, pathogenesis, molecular virology and the host response to HEV infection. The focus is on published literature in the past decade.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19208971     DOI: 10.1007/s12038-008-0064-1

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  117 in total

1.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Mutations in the GDD motif of rubella virus putative RNA-dependent RNA polymerase affect virus replication.

Authors:  X Wang; S Gillam
Journal:  Virology       Date:  2001-07-05       Impact factor: 3.616

Review 3.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

Review 4.  A review of hepatitis E virus.

Authors:  J L Smith
Journal:  J Food Prot       Date:  2001-04       Impact factor: 2.077

5.  The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton.

Authors:  M Zafrullah; M H Ozdener; S K Panda; S Jameel
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp).

Authors:  S Agrawal; D Gupta; S K Panda
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

7.  Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States.

Authors:  F F Huang; G Haqshenas; D K Guenette; P G Halbur; S K Schommer; F W Pierson; T E Toth; X J Meng
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

9.  Development and evaluation of an efficient cell-culture system for Hepatitis E virus.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Eiji Kusano; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

10.  Chronic hepatitis E virus infection in liver transplant recipients.

Authors:  Elizabeth B Haagsma; Arie P van den Berg; Robert J Porte; Cornelis A Benne; Harry Vennema; Johan H J Reimerink; Marion P G Koopmans
Journal:  Liver Transpl       Date:  2008-04       Impact factor: 5.799

View more
  63 in total

1.  Molecular epidemiology of hepatitis E virus infections in Shanghai, China.

Authors:  Yumin Zhu; Fusheng Si; Dianjun Cao; Xiaoming Yu; Ruisong Yu; Shijuan Dong; Fenfen Huang; Yuanshu Zhang; Zhen Li
Journal:  Virol J       Date:  2011-12-15       Impact factor: 4.099

2.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

Review 4.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

5.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

6.  Distribution and Molecular Characterization of Hepatitis E virus in Domestic Animals and Wildlife in Croatia.

Authors:  Jelena Prpić; Silvija Černi; Dijana Škorić; Tomislav Keros; Dragan Brnić; Željko Cvetnić; Lorena Jemeršić
Journal:  Food Environ Virol       Date:  2015-03-28       Impact factor: 2.778

7.  Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.

Authors:  Brenton J Sanford; Tanja Opriessnig; Scott P Kenney; Barbara A Dryman; Laura Córdoba; Xiang-Jin Meng
Journal:  Vaccine       Date:  2012-08-17       Impact factor: 3.641

8.  Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses.

Authors:  Hongxia Ma; Lin Zheng; Yunbo Liu; Chenyan Zhao; Tim J Harrison; Yuyuan Ma; Shuhua Sun; Jingang Zhang; Youchun Wang
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain.

Authors:  Yogesh A Karpe; Kavita S Lole
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding.

Authors:  Tom S Y Guu; Zheng Liu; Qiaozhen Ye; Douglas A Mata; Kunpeng Li; Changcheng Yin; Jingqiang Zhang; Yizhi Jane Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.